Abdominal Obesity in Women with Polycystic Ovary Syndrome and Its Relationship with Diet, Physical Activity and Insulin Resistance: A Pilot Study

被引:6
作者
Jurczewska, Justyna [1 ]
Ostrowska, Joanna [1 ]
Chelchowska, Magdalena [2 ]
Panczyk, Mariusz [3 ]
Rudnicka, Ewa [4 ]
Kucharski, Marek [4 ]
Smolarczyk, Roman [4 ]
Szostak-Wegierek, Dorota [1 ]
机构
[1] Med Univ Warsaw, Fac Hlth Sci, Dept Clin Dietet, Ciolka 27, PL-01445 Warsaw, Poland
[2] Inst Mother & Child Hlth, Dept Screening Tests & Metab Diagnost, Kasprzaka 17a, PL-01211 Warsaw, Poland
[3] Med Univ Warsaw, Fac Hlth Sci, Dept Educ & Res Hlth Sci, PL-00581 Warsaw, Poland
[4] Med Univ Warsaw, Dept Gynecol Endocrinol, Karowa 2, PL-00315 Warsaw, Poland
关键词
polycystic ovary syndrome; abdominal obesity; visceral adipose tissue; subcutaneous adipose tissue; insulin resistance; HOMA-IR; HOMA-AD; L/A ratio; physical activity; diet; VISCERAL ADIPOSITY INDEX; HYPERTENSION DASH DIET; METABOLIC RISK-FACTORS; BODY-FAT DISTRIBUTION; SUBCUTANEOUS FAT; NONOBESE PATIENTS; OVERWEIGHT WOMEN; ASSOCIATION; TISSUE; PCOS;
D O I
10.3390/nu15163652
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Abdominal obesity is a common feature of women with polycystic ovary syndrome (PCOS), and it is known to exacerbate insulin resistance (IR). Improper dietary and physical activity patterns are crucial environmental factors involved in the development of obesity, and they can significantly influence the central deposition of adipose tissue. Therefore, in this cross-sectional study, we aimed to evaluate the relationship between abdominal adiposity (measured by VAT (visceral adipose tissue), SAT (subcutaneous adipose tissue), VAT/SAT ratio (visceral to subcutaneous fat ratio), and WHR (waist-to-hip ratio)) and the prevalence and odds ratios of IR (measured by the homeostatic model assessment of insulin resistance (HOMA-IR), the homeostatic model assessment-adiponectin (HOMA-AD) and leptin to adiponectin ratio (L/A ratio)) in 56 PCOS women. Furthermore, we investigated the relationship between these abdominal obesity indices and diet and physical activity. An original food frequency questionnaire and Actigraph GT3X-BT were used to assess adherence to the diet recommended in IR and the level of physical activity, respectively. We observed a higher prevalence of IR among women with higher VAT, VAT/SAT, and WHR values compared to women with normal values of those abdominal obesity indices. Moreover, VAT/SAT seemed to be the best predictor of IR measured by HOMA-IR and HOMA-AD. However, VAT appeared to be the best and strongest predictor of IR measured by the L/A ratio. We also observed that higher adherence to the diet recommended in IR and higher levels of vigorous physical activity were associated with lower values of central fat accumulation indices and a greater chance of their normal values. Our findings indicate that central obesity increases the odds of IR and supports the beneficial role of diet and physical activity in the management of abdominal obesity in PCOS women.
引用
收藏
页数:17
相关论文
共 50 条
  • [31] Association between polycystic ovarian morphology and insulin resistance in women with polycystic ovary syndrome
    Lee, Jeong Eun
    Park, Yubin
    Lee, Jisoo
    Chun, Sungwook
    [J]. CLINICAL AND EXPERIMENTAL REPRODUCTIVE MEDICINE-CERM, 2023, 50 (02): : 117 - 122
  • [32] The Relationship Between Insulin Resistance and Obesity and Serum Anti-Mullerian Hormone Level in Chinese Women with Polycystic Ovary Syndrome: A Retrospective, Single-Center Cohort Study
    Zhao, Han
    Zhou, Dexin
    Liu, Cong
    Zhang, Le
    [J]. INTERNATIONAL JOURNAL OF WOMENS HEALTH, 2023, 15 : 151 - 166
  • [33] Evaluation of the relationship between serum ferritin and insulin resistance and visceral adiposity index (VAI) in women with polycystic ovary syndrome
    Gokcen, Busra Basar
    Akdevelioglu, Yasemin
    Canan, Sultan
    Bozkurt, Nuray
    [J]. EATING AND WEIGHT DISORDERS-STUDIES ON ANOREXIA BULIMIA AND OBESITY, 2021, 26 (05) : 1581 - 1593
  • [34] Associations of plasma miRNAs with waist circumference and insulin resistance among women with polycystic ovary syndrome - Pilot study
    Wander, Pandora L.
    Enquobahrie, Daniel A.
    Bammler, Theo K.
    MacDonald, James W.
    Srinouanprachanh, Sengkeo
    Kaleru, Thanmai
    Khakpour, Dori
    Trikudanathan, Subbulaxmi
    [J]. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2022, 554
  • [35] Insulin resistance, dyslipidemia, and metabolic syndrome in women with polycystic ovary syndrome
    El-Mazny, Akmal
    Abou-Salem, Nermeen
    El-Sherbiny, Walid
    El-Mazny, Ahmed
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2010, 109 (03) : 239 - 241
  • [36] Galectin-3 is a potential biomarker to insulin resistance and obesity in women with polycystic ovary syndrome
    Alves, Michelle T.
    de Souza, Isabella D. P.
    Ferreira, Claudia N.
    Candido, Ana Lucia
    Bizzi, Mariana F.
    Oliveira, Flavia R.
    Reis, Fernando M.
    Gomes, Karina B.
    [J]. GYNECOLOGICAL ENDOCRINOLOGY, 2020, 36 (09) : 760 - 763
  • [37] Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome
    Ardawi, MSM
    Rouzi, AA
    [J]. FERTILITY AND STERILITY, 2005, 83 (06) : 1708 - 1716
  • [38] Assessment of insulin resistance in young women with polycystic ovary syndrome
    Jensterle, Mojca
    Weber, Matthias
    Pfeifer, Marija
    Prezelj, Janez
    Pfutzner, Andreas
    Janez, Andrej
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2008, 102 (02) : 137 - 140
  • [39] Effect of Implanon on insulin resistance in women with Polycystic Ovary Syndrome
    Meyer, C
    Talbot, M
    Teede, H
    [J]. AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 2005, 45 (02) : 155 - 158
  • [40] Central arterial stiffness and diastolic dysfunction are associated with insulin resistance and abdominal obesity in young women but polycystic ovary syndrome does not confer additional risk
    Rees, E.
    Coulson, R.
    Dunstan, F.
    Evans, W. D.
    Blundell, H. L.
    Luzio, S. D.
    Dunseath, G.
    Halcox, J. P.
    Fraser, A. G.
    Rees, D. A.
    [J]. HUMAN REPRODUCTION, 2014, 29 (09) : 2041 - 2049